| |
| |
|
| Insider
Information: |
Schwab Andrew J. |
| Relationship: |
10% Owner |
| City: |
Burlington |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
16 |
|
| Direct
Shares |
0 |
|
|
Indirect Shares
|
10,770,294 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$22,633,460 |
|
|
| Total
Shares |
10,770,294 |
|
|
| Total
Value |
$22,633,460 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
18
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
18
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-18.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -1,674.9%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Flexion Therapeutics Inc |
FLXN |
Director, 10% Owner |
|
0 |
2014-02-18 |
1,512,076 |
Premium* |
|
|
Cidara Therapeutics, Inc. |
CDTX |
10% Owner |
|
0 |
2015-04-20 |
50,412 |
Premium* |
|
|
Crinetics Pharmaceuticals, Inc. |
CRNX |
Former 10% holder |
2018-07-20 |
0 |
2019-06-21 |
94,489 |
Premium* |
|
|
Arvinas Holding Company, Llc |
ARVN |
10% Owner |
2018-10-01 |
0 |
2019-09-16 |
1,002 |
Premium* |
|
|
Ideaya Biosciences, Inc. |
IDYA |
10% Owner |
|
0 |
2019-05-28 |
500,000 |
Premium* |
|
|
Aprea Therapeutics, Inc. |
APRE |
10% Owner |
|
0 |
2019-10-02 |
12,670 |
Premium* |
|
|
Cabaletta Bio, Inc. |
CABA |
10% Owner |
2019-10-29 |
0 |
2021-11-01 |
333,144 |
Premium* |
|
|
Scpharmaceuticals Inc. |
SCPH |
10% Owner |
2020-05-26 |
0 |
2022-10-10 |
410,268 |
Premium* |
|
|
Akouos, Inc. |
AKUS |
10% Owner |
2020-06-30 |
0 |
2022-11-30 |
0 |
Premium* |
|
|
5:01 Acquisition Corp. |
FVAM |
Co-CEO, Director, 10% ... |
2020-10-16 |
0 |
2020-11-12 |
365,126 |
Premium* |
|
|
Q32 Bio Inc |
QTTB |
10% Owner |
2020-12-14 |
0 |
2020-12-22 |
181,435 |
Premium* |
|
|
Vor Biopharma Inc. |
VOR |
10% Owner |
2021-02-09 |
0 |
2021-11-16 |
1,766,634 |
Premium* |
|
|
Rallybio Corp |
RLYB |
10% Owner |
|
0 |
2021-07-29 |
3,575,340 |
Premium* |
|
|
Entrada Therapeutics, Inc. |
TRDA |
10% Owner |
|
0 |
2021-11-02 |
1,132,357 |
Premium* |
|
|
Pear Therapeutics, Inc |
PEAR |
10% Owner |
2021-12-03 |
0 |
2023-04-10 |
200,000 |
Premium* |
|
|
Enliven Therapeutics Ord Shs |
ELVN |
10% Owner |
2023-02-23 |
0 |
2024-02-14 |
635,341 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
71 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2014-02-11 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,299 |
|
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
10% Owner |
– – • |
2015-04-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
196,849 |
|
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
10% Owner |
– – • |
2019-05-22 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
316,875 |
|
- |
|
| APRE |
Aprea Therapeutics, Inc. |
10% Owner |
– – • |
2019-10-02 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
12,670 |
|
- |
|
| RLYB |
Rallybio Corp |
10% Owner |
– – • |
2021-07-29 |
3/A |
IO |
$0.00 |
$0 |
I/I |
0 |
3,575,340 |
|
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
10% Owner |
– – • |
2021-10-28 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
331,155 |
|
- |
|
| FLXN |
Flexion Therapeutics Inc |
Director |
– • • |
2014-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,499,777 |
1,512,076 |
0 |
- |
|
| CDTX |
Cidara Therapeutics, Inc. |
10% Owner |
– – • |
2015-04-20 |
4 |
A |
$0.00 |
$0 |
I/I |
1,809,662 |
50,412 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2018-07-20 |
4 |
A |
$0.00 |
$0 |
I/I |
3,384,278 |
135,369 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
10% Owner |
– – • |
2018-10-01 |
4 |
A |
$0.00 |
$0 |
I/I |
4,989,552 |
125,360 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2019-02-20 |
4 |
D |
$0.00 |
$0 |
I/I |
(474,700) |
0 |
0 |
- |
|
| CRNX |
Crinetics Pharmaceuticals... |
10% Owner |
– – • |
2019-02-20 |
4 |
A |
$0.00 |
$0 |
I/I |
9,869 |
1,723 |
0 |
- |
|
| IDYA |
Ideaya Biosciences, Inc. |
10% Owner |
– – • |
2019-05-28 |
4 |
A |
$0.00 |
$0 |
I/I |
2,396,191 |
108,521 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
10% Owner |
– – • |
2019-09-16 |
4 |
A |
$0.00 |
$0 |
I/I |
137,636 |
1,002 |
0 |
- |
|
| ARVN |
Arvinas Holding Company, ... |
10% Owner |
– – • |
2019-09-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(450,000) |
79,856 |
0 |
- |
|
| CABA |
Cabaletta Bio, Inc. |
10% Owner |
– – • |
2019-10-29 |
4 |
A |
$0.00 |
$0 |
I/I |
3,214,721 |
3,214,721 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
10% Owner |
– – • |
2020-06-30 |
4 |
A |
$0.00 |
$0 |
I/I |
4,311,667 |
799,984 |
0 |
- |
|
| VOR |
Vor Biopharma Inc. |
10% Owner |
– – • |
2021-02-09 |
4 |
A |
$0.00 |
$0 |
I/I |
6,136,874 |
1,414,026 |
0 |
- |
|
| TRDA |
Entrada Therapeutics, Inc... |
10% Owner |
– – • |
2021-11-02 |
4 |
A |
$0.00 |
$0 |
I/I |
3,827,224 |
882,357 |
0 |
- |
|
| AKUS |
Akouos, Inc. |
10% Owner |
– – • |
2022-11-30 |
4 |
D |
$0.00 |
$0 |
I/I |
(4,135,786) |
0 |
0 |
- |
|
| ELVN |
Enliven Therapeutics Ord ... |
Director |
– • – |
2023-02-23 |
4 |
A |
$0.00 |
$0 |
I/I |
5,798,475 |
960,383 |
0 |
- |
|
| PEAR |
Pear Therapeutics, Inc |
10% Owner |
– – • |
2022-09-16 |
4 |
S |
$1.75 |
$614 |
I/I |
(351) |
541,235 |
0 |
% |
|
| PEAR |
Pear Therapeutics, Inc |
10% Owner |
– – • |
2022-11-01 |
4 |
S |
$2.80 |
$4,108 |
I/I |
(1,467) |
539,489 |
0 |
% |
|
| PEAR |
Pear Therapeutics, Inc |
10% Owner |
– – • |
2022-08-17 |
4 |
S |
$1.71 |
$17,232 |
I/I |
(10,077) |
603,272 |
0 |
% |
|
| PEAR |
Pear Therapeutics, Inc |
10% Owner |
– – • |
2022-11-02 |
4 |
S |
$2.72 |
$28,772 |
I/I |
(10,578) |
539,066 |
0 |
% |
|
71 Records found
|
|
Page 1 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
